{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:19:02Z","timestamp":1770218342585,"version":"3.49.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1681\/asn.2014090947","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T02:36:31Z","timestamp":1434076591000},"page":"314-322","source":"Crossref","is-referenced-by-count":58,"title":["Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD"],"prefix":"10.1681","volume":"27","author":[{"given":"Rukshana","family":"Shroff","sequence":"first","affiliation":[]},{"given":"Helen","family":"Aitkenhead","sequence":"additional","affiliation":[]},{"given":"Nikola","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Antonella","family":"Trivelli","sequence":"additional","affiliation":[]},{"given":"Mieczyslaw","family":"Litwin","sequence":"additional","affiliation":[]},{"given":"Stefano","family":"Picca","sequence":"additional","affiliation":[]},{"given":"Ali","family":"Anarat","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Sallay","sequence":"additional","affiliation":[]},{"given":"Fatih","family":"Ozaltin","sequence":"additional","affiliation":[]},{"given":"Aleksandra","family":"Zurowska","sequence":"additional","affiliation":[]},{"given":"Augustina","family":"Jankauskiene","sequence":"additional","affiliation":[]},{"given":"Giovanni","family":"Montini","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Charbit","sequence":"additional","affiliation":[]},{"given":"Franz","family":"Schaefer","sequence":"additional","affiliation":[]},{"given":"Elke","family":"W\u00fchl","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-33-20230208","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1681\/ASN.2007101079","article-title":"The aggravating mechanisms of aldosterone on kidney fibrosis.","volume":"19","author":"Remuzzi","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R2-33-20230208","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0140-6736(00)04728-0","article-title":"Progression, remission, regression of chronic renal diseases.","volume":"357","author":"Ruggenenti","year":"2001","journal-title":"Lancet"},{"key":"R3-33-20230208","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","article-title":"Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.","volume":"57","author":"Taal","year":"2000","journal-title":"Kidney Int"},{"key":"R4-33-20230208","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children.","volume":"361","author":"W\u00fchl","year":"2009","journal-title":"N Engl J Med"},{"key":"R5-33-20230208","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1046\/j.1523-1755.2003.00033.x","article-title":"Retarding progression of chronic renal disease: the neglected issue of residual proteinuria.","volume":"63","author":"Ruggenenti","year":"2003","journal-title":"Kidney Int"},{"key":"R6-33-20230208","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"key":"R7-33-20230208","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1681\/ASN.2004121074","article-title":"Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?","volume":"16","author":"Vogt","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R8-33-20230208","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1136\/bmj.e42","article-title":"The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis.","volume":"344","author":"Harel","year":"2012","journal-title":"BMJ"},{"key":"R9-33-20230208","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.M705495200","article-title":"1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.","volume":"282","author":"Yuan","year":"2007","journal-title":"J Biol Chem"},{"key":"R10-33-20230208","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/ndt\/gfq537","article-title":"Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy.","volume":"26","author":"Yoon","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R11-33-20230208","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1681\/ASN.2006091028","article-title":"Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.","volume":"18","author":"Mizobuchi","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R12-33-20230208","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"R13-33-20230208","doi-asserted-by":"crossref","first-page":"15896","DOI":"10.1073\/pnas.0803751105","article-title":"Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-33-20230208","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"R15-33-20230208","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrcardio.2009.135","article-title":"Vitamin D status and arterial hypertension: a systematic review.","volume":"6","author":"Pilz","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"R16-33-20230208","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00467-011-2071-y","article-title":"Can vitamin D slow down the progression of chronic kidney disease?","volume":"27","author":"Shroff","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R17-33-20230208","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2013030203","article-title":"Active vitamin D treatment for reduction of residual proteinuria: a systematic review.","volume":"24","author":"de Borst","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R18-33-20230208","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2010091001","article-title":"Changes in albuminuria predict mortality and morbidity in patients with vascular disease.","volume":"22","author":"Schmieder","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R19-33-20230208","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1681\/ASN.2006050520","article-title":"Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.","volume":"17","author":"Tan","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R20-33-20230208","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/ki.2008.452","article-title":"Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium.","volume":"74","author":"Kong","year":"2008","journal-title":"Kidney Int"},{"key":"R21-33-20230208","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease.","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int"},{"key":"R22-33-20230208","first-page":"S41","article-title":"An open label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease.","volume":"95","author":"Krairittichai","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"R23-33-20230208","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.ajkd.2009.04.036","article-title":"Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.","volume":"54","author":"Fishbane","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R24-33-20230208","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ajkd.2011.09.014","article-title":"Oral calcitriol for reduction of proteinuria in patients with IgA nephropathy: a randomized controlled trial.","volume":"59","author":"Liu","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R25-33-20230208","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"key":"R26-33-20230208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ndt\/gft360","article-title":"The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.","volume":"29","author":"Molina","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R27-33-20230208","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jc.2012-2790","article-title":"Effect of a 300 000-IU loading dose of ergocalciferol (Vitamin D2) on circulating 1,25(OH)2-vitamin D and fibroblast growth factor-23 (FGF-23) in vitamin D insufficiency.","volume":"98","author":"Turner","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-33-20230208","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S2213-8587(14)70113-5","article-title":"Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study.","volume":"2","author":"Vimaleswaran","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R29-33-20230208","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/HJH.0000000000000381","article-title":"Interaction effect of serum 25-hydroxyvitamin D levels and CYP1A1, CYP1B1 polymorphisms on blood pressure in an elderly population.","volume":"33","author":"Park","year":"2015","journal-title":"J Hypertens"},{"key":"R30-33-20230208","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ndt\/gfs411","article-title":"Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.","volume":"28","author":"Wan","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R31-33-20230208","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/01.HYP.0000013734.33441.EA","article-title":"In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage.","volume":"39","author":"Mitani","year":"2002","journal-title":"Hypertension"},{"key":"R32-33-20230208","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000316703","article-title":"Role of Fosinopril and Valsartan on Klotho Gene Expression Induced by Angiotensin II in Rat Renal Tubular Epithelial Cells.","volume":"33","author":"Zhou","year":"2010","journal-title":"Kidney Blood Press Res"},{"key":"R33-33-20230208","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MNH.0b013e32835422ad","article-title":"Klotho in health and disease.","volume":"21","author":"Kuro-o","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R34-33-20230208","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1681\/ASN.2010111190","article-title":"Klotho: an elixir of youth for the vasculature?","volume":"22","author":"Shroff","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R35-33-20230208","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.jrn.2014.06.009","article-title":"In Chronic Kidney Disease, Serum alpha-Klotho is Related to Serum Bicarbonate and Proteinuria","volume":"24","author":"Hage","year":"2014","journal-title":"J Ren Nutr"},{"key":"R36-33-20230208","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2215\/CJN.02700313","article-title":"Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.","volume":"8","author":"Karalliedde","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R37-33-20230208","doi-asserted-by":"crossref","first-page":"F647","DOI":"10.1152\/ajprenal.00090.2011","article-title":"Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy.","volume":"302","author":"Sanchez-Ni\u00f1o","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"R38-33-20230208","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.jrn.2010.07.002","article-title":"Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions.","volume":"21","author":"Isakova","year":"2011","journal-title":"J Ren Nutr"},{"key":"R39-33-20230208","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00467-011-2045-0","article-title":"Urinary and dialysate losses of vitamin D-binding protein in children on chronic peritoneal dialysis.","volume":"27","author":"Prytu\u0142a","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R40-33-20230208","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jsbmb.2011.09.002","article-title":"Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease.","volume":"128","author":"Doorenbos","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R41-33-20230208","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1097\/00004872-200210000-00019","article-title":"Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions.","volume":"20","author":"W\u00fchl","year":"2002","journal-title":"J Hypertens"},{"key":"R42-33-20230208","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1093\/ndt\/gfm300","article-title":"Urinary excretion of endothelin-1 (ET-1), transforming growth factor-beta1 (TGF-beta1) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial.","volume":"22","author":"Grenda","year":"2007","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00001751-201601000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T23:19:42Z","timestamp":1675898382000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001751-201601000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014090947","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}